Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Mills

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Journal of Hepatology|December 3, 2013
Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trialD Shoeb, J Dearden, A Weatherall, et al.
Alimentary Pharmacology & Therapeutics|February 3, 2012
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patientsP Ramachandran, A Fraser, K Agarwal, et al.
Journal of Viral Hepatitis|August 12, 2016
A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapyE J Aspinall, W Mitchell, J Schofield, et al.
Journal of Viral Hepatitis|April 11, 2014
Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action PlanS A McDonald, S J Hutchinson, H A Innes, et al.
Journal of Viral Hepatitis|March 27, 2018
Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysisH Wang, R Swann, E Thomas, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Journal of Hepatology|December 3, 2013
Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trialD Shoeb, J Dearden, A Weatherall, et al.
Alimentary Pharmacology & Therapeutics|February 3, 2012
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patientsP Ramachandran, A Fraser, K Agarwal, et al.
Journal of Viral Hepatitis|August 12, 2016
A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapyE J Aspinall, W Mitchell, J Schofield, et al.
Journal of Viral Hepatitis|April 11, 2014
Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action PlanS A McDonald, S J Hutchinson, H A Innes, et al.
Journal of Viral Hepatitis|March 27, 2018
Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysisH Wang, R Swann, E Thomas, et al.
Pageof 15